Todd Anderman
General Counsel at Ocular Therapeutix, Inc (OCUL)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $225K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 13SEC | OCULOcular Therapeutix, Inc | Sell Plan | 11,984140,484 held (−8%) | $7.29 | $87K | -5.8% |
| Oct 10SEC | OCULOcular Therapeutix, Inc | Sell Plan | 11,13287,568 held (−11%) | $12.34 | $137K | -44.3% |
- Sell
General Counsel Todd Anderman sold $87K of OCUL at $7.29 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Todd Anderman sold $137K of OCUL at $12.34 — pre-scheduled 10b5-1 plan sale.